National Centre for Neuroimmunologyand Emerging Diseases

Publicat ions

2019 Balinas C, Cabanas H, Staines D, Marshall-Gradisnik S: Transient

receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients: Journal of Translational Medicine 17, 401, 2019 https://doi.org/10.1186/s12967-019-02155-4

Barnden L, Shan Z, Staines D, Marshall-Gradisnik S, Finegan K, Ireland T, Bhuta S: Intra brainstem connectivity is impaired in chronic fatigue syndrome: Neuroimage Clinical, 2019 https://doi.org/10.1016/j.nicl.2019.102045

Eaton-Fitch N, du Preez S, Cabanas H, Staines D, Marshall-Gradisnik S: A Systematic Review of Natural Killer Cells Profile and Cytotoxic Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Systematic Reviews, 2019, https://doi.org/10.1186/s13643-019-1202-6

Cabanas H, Muraki K, Staines D, Marshall-Gradisnik S: Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients. Frontiers in Immunology 2019 https://doi.org/10.3389/fimmu.2019.02545

Corbitt M, Eaton-Fitch N, Staines D, Cabanas H, Marshall-Gradisnik S.A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID). BMC Neurology 2019 https://doi.org/10.1186/s12883-019-1433-0

Cabanas H, Muraki K, Balinas C, Eaton-Fitch, N, Staines D and Marshall-Gradisnik S. Validation of impaired transient receptor Potential Melastatin 3 ion channel activity in Natural Killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients. Molecular Medicine 2019 25(1):14 https://doi.org/10.1186/s10020-019-0083-4

Balinas C, Cabanas H, Staines D and Marshall-Gradisnik S. Identification and characterisation of Transient receptor potential melastatin 2 and CD38 channels on Natural Killer cells using the novel application of flow cytometry. BMC Immunology 2019 20(1):14 doi: 10.1186/s12865-019-0293-0 https://doi.org/10.1186/s12865-019-0293-0

Knight S, Elders S, Rodda J, Harvey A, Lubitz L, Rowe K, Reveley C, Hennel S, Towns S, Kozlowska K, Payne DN, Marshall-Gradisnik S, Scheinberg A. Epidemiology of paediatric chronic fatigue syndrome in Australia. Archives of Disease in Childhood, https://doi.org/10.1136/archdischild-2018-316450

Słomko J, Newton J L, Kujawski S, Tafil-Klawe M, Klawe J, Staines D, Marshall-Gradisnik S, Zalewski P: Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study. BMJ Open 2019;9:e023955. https://doi.org/10.1136/bmjopen-2018-023955

2018 Du Preez S, Corbitt M, Cabanas H, Eaton N, Staines D, Marshall-

Gradisnik S: A Systematic Review of Enteric Dysbiosis in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Systematic Reviews, 2018, 7:241 https://doi.org/10.1186/s13643-018-0909-0

Cabanas H, Muraki K, Eaton N, Balinas C, Staines D, Marshall-Gradisnik S: Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Molecular Medicine, 2018, 24:44. https://doi.org/10.1186/s10020-018-0046-1

Clarke L, Broadley SL, Nguyen T, Johnston S, Eaton N, Staines D & Marshall-Gradisnik S: Transient Receptor Potential Melastatin 3 and Intracellular Calcium in Natural Killer Cells in Multiple Sclerosis. International Journal of Clinical Medicine, 2018, 9:541-565. doi: 10.4236/ijcm.2018.97047 IF 0.69.

Nguyen T, Staines D, Johnston S & Marshall-Gradisnik S: Reduced glycolytic reserve in isolated natural killer cells fromMyalgic Encephalomyelitis/Chronic Fatigue Syndrome patients: A preliminary investigation. Asian Pacific Journal of Allergy and Immunology, 2018, July doi: 10.12932/AP-011117-0188

Barnden L, Shan Z, Staines D, Marshall-Gradisnik S, Finegan K, Ireland T, Bhuta S: Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome. NeuroImage Clinical, 2018, 20:102-109. https://doi.org/10.1016/j.nicl.2018.07.011

Staines D, Du Preez S, Cabanas H, Balinas C, Eaton N, Passmore R, Maksoud R, Redmayne J & Marshall-Gradisnik S: Transient Receptor Potential Ion Channels in the Etiology and Pathomechanism of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. International Journal of Clinical Medicine, 2018, 9:445-453. doi: 10.4236/ijcm.2018.95038 IF 0.69.

Marshall-Gradisnik S, Fretel M, Eaton N, Cabanas H, Balinas C, Gopalan V, Petersen D, Passmore R, Tang K, Haque M, Lam A, Staines D:

Decreased expression of TRPM3 and mAChRM3 in the small intestine in chronic fatigue syndrome/myalgic encephalomyelitis. International Journal of Clinical Medicine, 2018, 9:467-480. doi: 10.4236/ijcm.2018.95040 IF 0.69.

Shan ZY, Finegan K, Bhuta S, Ireland T, Staines D, Marshall-Gradisnik S, Barnden L: Brain function characteristics of Chronic Fatigue Syndrome: a task fMRI study. Neuroimage: Clinical, 2018, 19:279-286. IF 4.515.

https://doi.org/10.1016/j.nicl.2018.04.025 Eaton N, Cabanas H, Balinas C, Klein A, Staines D, Marshall-Gradisnik

S: Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation. BMC Pharmacology & Toxicology, 2018, 19(1):12. IF 2.288. https://doi.org/10.1186/s40360-018-0203-8

Cabanas H, Eaton N, Khalilidehkordi E, Broadly S, Balinas C, Du Preez S, Maksoud R, Staines D, Marshall-Gradisnik S: A pilot investigation of natural killer cell function and phenotypes in stable and active Multiple Sclerosis patients. Journal of Multiple Sclerosis, 2018, 5(1). doi: 10.4172/2376-0389.1000218 IF 1.16.

Shan ZY, Finegan K, Bhuta B, Ireland T, Staines DR, Marshall-Gradisnik S, Barnden LR: Decreased connectivity and increased blood oxygenation level dependant complexity in the default mode network in individuals with Chronic Fatigue Syndrome. Brain Connectivity, 2018, 8(1):33-39. IF 3.83. https://doi.org/10.1089/brain.2017.0549

Corbitt M, Campagnolo N, Staines DR, Marshall-Gradisnik SM: A systematic review of probiotic interventions for gastrointestinal symptoms and irritable bowel syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). Probiotics and Antimicrobial Proteins, 2018, September 10(3):466-477IF 1.324. https://doi.org/10.1007/s12602-018-9397-8

2017 Nguyen T, Johnston SC, Chacko A, Gibson D, Cepon J, Smith P, Staines

DR & Marshall-Gradisnik S: Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Asian Pacific Journal of Allergy and Immunology, 2017, 35(2):75-81. doi: 10.12932/AP0771 IF 1.46.

Balinas C, Nguyen T, Johnston S, Smith P, Staines D, Marshall-Gradisnik S: Investigation of mast cell toll-like receptor 3 in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Systemic Mastocytosis participants using the novel application of autoMACS

magnetic separation and flow cytometry (https://www.ncbi.nlm.nih.gov/pubmed/29223146). Asian Pacific Journal of Allergy and Immunology, 2017, Dec 10. https://doi.org/10.12932/AP-200517-0086

Nguyen T, Johnston S, Clarke L, Smith P, Staines D, Marshall‐Gradisnik S: Impaired calcium mobilization in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels (https://www.ncbi.nlm.nih.gov/pubmed/27727448). Clinical and Experimental Immunology, 2017, 187(2):284-293. doi: 10.1111/cei.12882 IF 3.41, Cited 2.

Campagnolo N, Johnston S, Collatz A, Staines D, Marshall-Gradisnik S: Dietary and nutrition interventions for the therapeutic treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: a systematic review (https://www.ncbi.nlm.nih.gov/pubmed/28111818). Journal of Human Nutrition and Dietetics, 2017, 30(3):247-259. IF 2.638, Cited 3. https://doi.org/10.1111/jhn.12435

Shan ZY, Kwiatek R, Burnet R, Del Fante P, Staines DR, Marshall-Gradisnik SM, Barnden LR: Medial prefrontal cortex deficits correlate with unrefreshing sleep in patients with Chronic Fatigue Syndrome. NMR in Biomedicine, 2017, 30(10). IF 3.53, Cited 2.

2016 Hardcastle S, Brenu E, Johnston S, Staines D, Marshall-Gradisnik S:

Severity Scales for Use in Primary Health Care to Assess Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Health Care for Women International, 2016, 37(6):671-86. doi: 10.1080/07399332.2014. IF 0.91, Cited 2.

Barnden LR, Kwiatek R, Crouch B, Burnet R, Del Fante P: Autonomic correlations with MRI are abnormal in the brainstem vasomotor centre in Chronic Fatigue Syndrome. NeuroImage: Clinical, 2016, 11:530-537. https://doi.org/10.1016/j.nicl.2016.03.017 IF 5.15, Cited 10.

Marshall-Gradisnik S, Huth T, Chacko A, Johnston S, Smith P, Staines D: Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (https://www.ncbi.nlm.nih.gov/pubmed/27099524). The Application of Clinical Genetics, 2016, 9:39-47. IF 4.20, Cited 9.

Ramos S, Brenu E, Broadley S, Kwiatek R, Ng J, Nguyen T, Freeman S, Staines D, Marshall-Gradisnik S: Regulatory T, natural killer T and gammadelta T cells in Multiple Sclerosis and Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: a comparison (https://www.ncbi.nlm.nih.gov/pubmed/27001659). Asian Pacific

Journal of Allergy and Immunology, 2016, 34(4):300-305. IF 1.46, Cited 2.

Nguyen T, Staines D, Nilius B, Smith P, Marshall-Gradisnik S: Novel identification and characterisation of transient receptor potential melastatin 3 ion channels on natural killer cells and B lymphocytes: effects on cell signalling in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients (https://www.ncbi.nlm.nih.gov/pubmed/27245705). Biological Research, 2016, 49(1):27. IF 1.79, Cited 3.

Johnston S, Staines D, Klein A, Marshall-Gradisnik S: A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. BMC Medical Genetics, 2016, 17(1):79. IF 2.38, Cited 3.

Johnston SC, Staines DR, Marshall-Gradisnik SM: Epidemiological characteristics of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis in Australian patients. (https://www.ncbi.nlm.nih.gov/pubmed/27279748). Clinical Epidemiology, 2016, 8:97-107. IF 7.056, Cited 2.

Simmonds M.J., Sabapathy S., Serre K.R., Haseler L.J., Gass G.C., Marshall-Gradisnik S.M., Minahan C.L.: Regular walking improves plasma protein concentrations that promote blood hyperviscosity in women 65-74 years with type 2 diabetes. Clinical Hemorheology and Microcirculation, 2016, 64(2):189-198. IF 1.20, Cited 1.

Collatz A, Johnston SC, Staines DR, Marshall-Gradisnik SM: A systematic review of drug therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (https://www.ncbi.nlm.nih.gov/pubmed/27229907). Clinical Therapeutics, 2016, 38(6):1263-1271. IF 0.86, Cited 2.

Chacko A, Staines DR, Johnston SC, Marshall-Gradisnik SM: Dysregulation of protein kinase gene expression in NK cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients (https://www.ncbi.nlm.nih.gov/pubmed/27594784). Gene Regulation and Systems Biology, 2016, 10:85-93. IF 3.86, Cited 2.

Huth TK, Brenu EW, Staines DR, Marshall-Gradisnik SM: Killer cell immunoglobulin-like receptor genotype and haplotype investigation of natural killer cells from an Australian population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. GeneRegulation and Systems Biology, 2016, 10:43-49. IF 3.86.

Marshall-Gradisnik SM, Chacko A, Johnston S, Smith P, Nilius B, Staines DR: Genotype frequencies of transient receptor potential melastatin M3 ion channels and acetylcholine muscarinic M3 receptor gene polymorphisms in Chronic Fatigue Syndrome/Myalgic

Encephalomyelitis patients (https://www.ncbi.nlm.nih.gov/pubmed/26881265). Immunology and Immunogenetics Insights, 2016, 8, 1-2.

Brenu EW, Broadley S, Nguyen T, Johnston S, Ramos S, Staines D, Marshall-Gradisnik S: A preliminary comparative assessment of the role of CD8+ T cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis. Journal of Immunology Research, 2016, (1):1-8. IF 0.61, Cited 4.

Marshall-Gradisnik S, Johnston S, Chacko A, Nguyen T, Smith P, Staines D: Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients (https://www.ncbi.nlm.nih.gov/pubmed/27834303). The Journal of International Medical Research, 2016, 44(6):1381-1394. IF 1.16, Cited 1.

Shan ZY, Kwiatek R, Burnet R, Del Fante P, Staines DR, Marshall-Gradisnik SM, Barnden LR: Progressive brain changes in pients with Chronic Fatigue Syndrome: A longitudinal MRI study (https://www.ncbi.nlm.nih.gov/pubmed/27123773). Journal of Magnetic Resonance Imaging, 2016, 44(5):1301-1311. IF 3.083, Cited 3.

Huth TK, Staines D, Marshall-Gradisnik S: ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dim CD16+ and CD56brightCD16dim/-Natural Killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelelitis patients. Journal of Translational Medicine, 2016, 14:97. IF 4.261, Cited 8.

Huth TK, Brenu EW, Ramos S, Nguyen T, Broadley S, Staines D, Marshall-Gradisnik S: Pilot study of natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis (https://www.ncbi.nlm.nih.gov/pubmed/26381393). Scandinavian Journal of Immunology, 2016, 83(1):44-51. IF 2.256, Cited 2.

2015 Barnden LR, Crouch B, Kwiatek R, Burnet R, Del Fante P: Evidence in

Chronic Fatigue Syndrome for severity-dependent upregulation of prefrontal myelination that is independent of anxiety and depression (https://www.ncbi.nlm.nih.gov/pubmed?term=Evidence%20in%20chronic%20fatigue%20syndrome%20for%20severity-dependent%5BTitle%5D). NMR in Biomedicine, 2015, 28(3):404-413. doi: 10.1002/nbm.3261. IF 3.53, Cited 15.

Hardcastle S, Brenu E, Johnston S, Nguyen T, Huth T, Wong N, Ramos S, Staines D, Marshall-Gradisnik S: Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis

(CFS/ME) (https://www.ncbi.nlm.nih.gov/pubmed/26032326). BMC Immunology, 2015, 16:35. IF 2.57, Cited 13.

Marshall-Gradisnik S, Smith P, Nilius B, Staines DR: Examination of Single Nucleotide Polymorphisms in Acetylcholine Receptors in Chronic Fatigue Syndrome patients. Immunology and Immunogenetics Insights, 2015, 7:7-20. Cited 7.

Marshall-Gradisnik SM, Smith P, Brenu EW, Nilius B, Ramos SB, Staines DR: Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in Chronic Fatigue Syndrome patients. Immunology and Immunogenetics Insights, 2015, 7:1-6. Cited 1.

Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, Staines D, Marshall-Gradisnik S: Serum immune proteins in moderate and severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients (https://www.ncbi.nlm.nih.gov/pubmed/26516304). International Journal of Medical Sciences, 2015, 12(10):764-772. IF 2.59, Cited 6.

Ramos S, Brenu E, Nguyen T, Ng J, Staines D, Marshall-Gradisnik S: Characterisation of B cell subsets and receptors in Chronic Fatigue Syndrome patients. Journal of Clinical and Cellular Immunology, 2015, 6:288. IF 3.72.

Hardcastle S, Brenu E, Johnston S, Nguyen T, Huth T, Ramos S, Staines D, Marshall-Gradisnik S: Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Journal of Translational Medicine, 2015, 13:299. IF 4.261, Cited 6.

Peterson D, Brenu EW, Gottschalk G, Ramos S, Nguyen T, Staines D, Marshall-Gradisnik S: Cytokines in the cerebrospinal fluids of patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (https://www.ncbi.nlm.nih.gov/pubmed/25834308). Mediators of Inflammation, 2015, doi:10.1155/2015/929720. Epub 2015 Mar 5. IF 3.89, Cited 9.

2014 Hardcastle S, Brenu E, Staines D, Marshall-Gradisnik S: Chronic Fatigue

Syndrome/Myalgic Encephalomyelitis and the potential role of T cells. Biological Markers and Guided Therapy, 2014, 1(1):25-38.

Johnston S, Brenu E, Hardcastle S, Huth T, Staines D, Marshall-Gradisnik S: A comparison of health status in patients meeting alternative definitions for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (https://www.ncbi.nlm.nih.gov/pubmed/24886213). Health and Quality of Life Outcomes, 2014, 12:64. IF 2.914, Cited 5.

Brenu E, Huth T, Hardcastle S, Fuller K, Kaur M, Johnston S, Ramos S, Staines D, Marshall-Gradisnik S: Role of adaptive and innate immune cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (https://www.ncbi.nlm.nih.gov/pubmed?term=(Role%20of%20adaptive%5BTitle%5D%20AND%20innate%20immune%20cells%20in%20chronic%20fatigue%20syndrome%5BTitle%5D). International Immunology, 2014, 26(4):233-42. doi: 10.1093/intimm/dxt068 IF 3.325, Cited 24.

Johnston S, Brenu E, Staines D, Marshall-Gradisnik S: The role of clinical guidelines for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis in research settings. Fatigue: Biomedicine, Health & Behavior, 2014, 2(1):28-39.

Hardcastle S, Brenu E, Johnston S, Nguyen T, Huth T, Kaur M, Ramos S, Salajegheh A, Staines D, Marshall-Gradisnik SM: Analysis of the relationship between immune dysfunction and symptom severity in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). Journal of Clinical and Cellular Immunology, 2014, 5:190. IF 3.72.

Huth T, Brenu E, Nguyen T, Hardcastle S, Johnston S, Ramos S, Staines D, Marshall-Gradisnik S: Characterisation of natural killer cell phenotypes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Journal of Clinical and Cellular Immunology, 2014, 5:223. IF 3.72.

Brenu E, Staines D, Marshall-Gradisnik S: Methylation Profile of CD4+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Journal of Clinical and Cellular Immunology, 2014, 5:228. IF 3.72.

Kakanis MW, Peake J, Brenu EW, Simmonds M, Gray B, Marshall-Gradisnik SM: T helper cell cytokine profiles after endurance exercise. Journal of Interferon and Cytokine Research, 2014, 34(9):699-706. IF 2.36, Cited 8.

Nguyen T, Brenu, EW, Staines DR, Marshall-Gradisnik SM: MicroRNAs in the Intracellular Space, Regulation of Organelle Specific Pathways in Health and Disease. MicroRNA, 2014, 3(2):98-107. Cited 1.

Brenu E, Ashton K, Batovska J, Staines D, Marshall-Gradisnik S: High-throughput sequencing of plasma microRNA in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. PloS One, 2014, https://doi.org/10.1371/journal.pone.0102783. Cited 9.

2013 Huth T, Brenu E, Ashton K, Staines D, Marshall-Gradisnik SM: Natural

killer cell cytotoxicity activity: Measurement of the apoptotic inducing mechanisms. Clinical and Experimental Medical Sciences, 2013, 1(8): 373-386. Cited 1.

Brenu EW, Johnston S, Hardcastle SL, Huth TK, Fuller K, Ramos S, Staines DR, Marshall-Gradisnik S: Immune abnormalities in patients meeting new diagnostic criteria for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Journal of Molecular Biomarkers & Diagnosis, 2013, 4:152. IF 3.65.

Johnston S, Brenu E, Staines D, Marshall-Gradisnik S: The adoption of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis case definitions to assess prevalence: a systematic review. Annals of Epidemiology, 2013, 23(6):371-376. IF 2.75, Cited 22.

Brenu E.W., Staines D.R, Tajouri L., Huth T.K., Ashton K.J., Marshall-Gradisnik S.M: Heat Shock Proteins and Regulatory T cells. Autoimmune Diseases, 2013, 813256. doi: 10.1155/2013/813256. Epub 2013 Mar 14. Cited 7.

Brenu E, Hardcastle S, Atkinson G, van Driel M, Kreijkamp-Kaspers S, Ashton K, Staines D, Marshall-Gradisnik S: Natural killer cells in patients with severe Chronic Fatigue Syndrome. Autoimmunity Highlights, 2013, 4(3):69-80. IF 0.92, Cited 16.

Johnston S, Brenu E, Staines D, Marshall-Gradisnik S: The prevalence of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: a meta-analysis. Clinical Epidemiology, 2013, 5:105-110. IF 7.056, Cited 24.

Brenu EW, Atkinson GM, van Driel ML, Kreijkamp-Kaspers S, Staines DR, Marshall-Gradisnik SM: Enhanced Gene Expression Following Vaccination in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. International Journal of Clinical Medicine, 2013, 4:165-170. IF 0.67.

2012 Simmonds MJ, Minahan CL, Serre KR, Gass GC, Marshall-Gradisnik

SM, Haseler LJ, Sabapathy S: Preliminary findings in the heart rate variability and hemorheology responses to varied frequency and duration of walking in women 65-74 years with type 2 diabetes. Clinical Hemorheology and Microcirculation, 2012, 51(2):87-99. IF 1.20, Cited 20.

Brenu E, van Driel M, Staines D, Kreijkamp-Kaspers S, Hardcastle S, Marshall-Gradisnik S: The effects of influenza vaccination on immune function in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. International Journal of Clinical Medicine, 2012, 3:544-551. IF 0.67, Cited 3.

Brenu E, Ashton K, van Driel M, Staines D, Peterson D, Atkinson G, Marshall-Gradisnik S: Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (https://www.ncbi.nlm.nih.gov/pubmed/22572093). Journal of Affective Disorders, 2012, 141(2-3):261-269. IF 4.40, Cited 28.

Brenu E, van Driel M, Staines D, Ashton K, Hardcastle S, Keane J, Tajouri L, Peterson D, Ramos SB, Marshall-Gradisnik SM: Longitudinal investigation of natural killer cells and cytokines in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Journal of Translational Medicine, 2012, 10(1):88. IF 3.92, Cited 70.